Association of p53 Arg72Pro polymorphism with gastric cancer: a meta-analysis

References

• Asslaber D, Piñón JD, Seyfried I, Desch P, Stöcher M, Tinhofer I, Egle A, Merkel O, Greil R. (2010). microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia. Blood 115:4191–4197.
   PubMed Web of Science ®Google Scholar
• Belyavskaya VA, Vardosanidze VK, Smirnova OY, Karakin EI, Savkin IV, Gervas PA, Cherdyntseva NV, Voevoda MI. (2006). Genetic status of p53 in stomach cancer: Somatic mutations and polymorphism of codon 72. Bull Exp Biol Med 141:243–246.
   PubMed Web of Science ®Google Scholar
• Bennett WP, Hussain SP, Vahakangas KH, Khan MA, Shields PG, Harris CC. (1999). Molecular epidemiology of human cancer risk: Gene-environment interactions and p53 mutation spectrum in human lung cancer. J Pathol 187:8–18.
   PubMed Web of Science ®Google Scholar
• Bergamaschi D, Samuels Y, Sullivan A, Zvelebil M, Breyssens H, Bisso A, Del Sal G, Syed N, Smith P, Gasco M, Crook T, Lu X. (2006). iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53. Nat Genet 38:1133–1141.
   PubMed Web of Science ®Google Scholar
• Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E, Malvezzi M, La Vecchia C. (2009). Recent patterns in gastric cancer: A global overview. Int J Cancer 125:666–673.
   PubMed Web of Science ®Google Scholar
• Brady CA, Attardi LD. (2010). p53 at a glance. J Cell Sci 123:2527–2532.
   PubMed Web of Science ®Google Scholar
• Brosh R, Rotter V. (2009). When mutants gain new powers: News from the mutant p53 field. Nat Rev Cancer 9:701–713.
   PubMed Web of Science ®Google Scholar
• Carneiro F, Oliveira C, Seruca R. (2010). Pathology and genetics of familial gastric cancer. Int J Surg Pathol 18:33S–36S.
   Web of Science ®Google Scholar
• Chung WC, Lee KM, Lee BI, Chun JS, Lee SY, Chang UI, Park SH, Yang JM, Choi KY, Chung IS. (2006). P53 genetic polymorphism of gastric cancer in Korea. Korean J Intern Med 21:28–32.
   PubMedGoogle Scholar
• DerSimonian R, Laird N. (1986). Meta-analysis in clinical trials. Control Clin Trials 7:177–188.
   PubMed Web of Science ®Google Scholar
• Dumont P, Leu JI, Della Pietra AC 3rd, George DL, Murphy M. (2003). The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33:357–365.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634.
   PubMed Web of Science ®Google Scholar
• Gomes de Souza L, Miranda de Lima J, Dale Cotrim Guerreiro da Silva I, Manoukian Forones N. (2009). P53 Arg72Pro polymorphism in gastric cancer patients. J Gastrointest Cancer 40:41–45.
   PubMedGoogle Scholar
• Hamajima N, Matsuo K, Suzuki T, Nakamura T, Matsuura A, Hatooka S, Shinoda M, Kodera Y, Yamamura Y, Hirai T, Kato T, Tajima K. (2002). No associations of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese. Cancer Lett 181:81–85.
   PubMed Web of Science ®Google Scholar
• Hiyama T, Tanaka S, Kitadai Y, Ito M, Sumii M, Yoshihara M, Shimamoto F, Haruma K, Chayama K. (2002). p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis. Int J Cancer 100:304–308.
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. (2011). Global cancer statistics. CA Cancer J Clin 61:69–90.
   PubMed Web of Science ®Google Scholar
• Ke-Xiang Z, Yu-Min L, Xun L, Wen-Ce Z, Yong S, Tao L. (2012). Study on the association of p53 codon 72 polymorphisms with risk of gastric cancer in high incidence Hexi area of Gansu Province in China. Mol Biol Rep 39:723–728.
   PubMedGoogle Scholar
• Kim N, Cho SI, Lee HS, Park JH, Kim JH, Kim JS, Jung HC, Song IS. (2010). The discrepancy between genetic polymorphism of p53 codon 72 and the expression of p53 protein in Helicobacter pylori-associated gastric cancer in Korea. Dig Dis Sci 55:101–110.
   PubMed Web of Science ®Google Scholar
• Lai KC, Chen WC, Tsai FJ, Li SY, Jeng LB. (2005). Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer. Hepatogastroenterology 52:944–948.
   PubMedGoogle Scholar
• Li Z, Ni M, Li J, Zhang Y, Ouyang Q, Tang C. (2011). Decision making of the p53 network: Death by integration. J Theor Biol 271:205–211.
   PubMed Web of Science ®Google Scholar
• Li J, Fine JP. (2011). Assessing the dependence of sensitivity and specificity on prevalence in meta-analysis. Biostatistics 12:710–722.
   PubMed Web of Science ®Google Scholar
• Lim EH, Zhang SL, Li JL, Yap WS, Howe TC, Tan BP, Lee YS, Wong D, Khoo KL, Seto KY, Tan L, Agasthian T, Koong HN, Tam J, Tan C, Caleb M, Chang A, Ng A, Tan P. (2009). Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC). J Thorac Oncol 4:12–21.
   PubMed Web of Science ®Google Scholar
• Ludovini V, Pistola L, Gregorc V, Floriani I, Rulli E, Piattoni S, Di Carlo L, Semeraro A, Darwish S, Tofanetti FR, Stocchi L, Mihaylova Z, Bellezza G, Del Sordo R, Daddi G, Crinò L, Tonato M. (2008). Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: A study of the perugia multidisciplinary team for thoracic oncology. J Thorac Oncol 3:365–373.
   PubMed Web of Science ®Google Scholar
• Mantel N, Haenszel W. (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748.
   PubMed Web of Science ®Google Scholar
• Milne AN, Carneiro F, O’Morain C, Offerhaus GJ. (2009). Nature meets nurture: Molecular genetics of gastric cancer. Hum Genet 126:615–628.
   PubMed Web of Science ®Google Scholar
• Mu LN, Lu QY, Yu SZ, Jiang QW, Cao W, You NC, Setiawan VW, Zhou XF, Ding BG, Wang RH, Zhao J, Cai L, Rao JY, Heber D, Zhang ZF. (2005). Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population. Int J Cancer 116:972–983.
   PubMed Web of Science ®Google Scholar
• Oliveira C, Seruca R, Carneiro F. (2006). Genetics, pathology, and clinics of familial gastric cancer. Int J Surg Pathol 14:21–33.
   PubMed Web of Science ®Google Scholar
• Pérez-Pérez GI, Bosques-Padilla FJ, Crosatti ML, Tijerina-Menchaca R, Garza-González E. (2005). Role of p53 codon 72 polymorphism in the risk of development of distal gastric cancer. Scand J Gastroenterol 40:56–60.
   PubMed Web of Science ®Google Scholar
• Pim D, Banks L. (2004). p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 108:196–199.
   PubMed Web of Science ®Google Scholar
• Pinarbasi E, Percin FE, Yilmaz M, Akgun E, Cetin M, Cetin A. (2007). Association of microsomal epoxide hydrolase gene polymorphism and pre-eclampsia in Turkish women. J Obstet Gynaecol Res 33:32–37.
   PubMed Web of Science ®Google Scholar
• Santos LE, Guilhen AC, de Andrade RA, Sumi LG, Ward LS. (2011). The role of TP53 PRO47SER and ARG72PRO single nucleotide polymorphisms in the susceptibility to bladder cancer. Urol Oncol 29:291–294.
   PubMed Web of Science ®Google Scholar
• Shen H, Solari A, Wang X, Zhang Z, Xu Y, Wang L, Hu X, Guo J, Wei Q. (2004). P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population. Oncol Rep 11:1115–1120.
   PubMed Web of Science ®Google Scholar
• Shi H, Tan SJ, Zhong H, Hu W, Levine A, Xiao CJ, Peng Y, Qi XB, Shou WH, Ma RL, Li Y, Su B, Lu X. (2009). Winter temperature and UV are tightly linked to genetic changes in the p53 tumor suppressor pathway in Eastern Asia. Am J Hum Genet 84:534–541.
   PubMed Web of Science ®Google Scholar
• Själander A, Birgander R, Kivelä A, Beckman G. (1995). p53 polymorphisms and haplotypes in different ethnic groups. Hum Hered 45:144–149.
   PubMed Web of Science ®Google Scholar
• Song HR, Kweon SS, Kim HN, Piao JM, Yun WJ, Choi JS, Hwang JE, Yoon JY, Kim HR, Park YK, Kim SH, Choi YD, Shin MH. (2011). p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population. Gastric Cancer 14:242–248.
   PubMed Web of Science ®Google Scholar
• Sul J, Yu GP, Lu QY, Lu ML, Setiawan VW, Wang MR, Guo CH, Yu SZ, Mu L, Cai L, Kurtz RC, Zhang ZF. (2006). P53 Codon 72 polymorphisms: A case-control study of gastric cancer and potential interactions. Cancer Lett 238:210–223.
   PubMed Web of Science ®Google Scholar
• Sullivan A, Syed N, Gasco M, Bergamaschi D, Trigiante G, Attard M, Hiller L, Farrell PJ, Smith P, Lu X, Crook T. (2004). Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene 23:3328–3337.
   PubMed Web of Science ®Google Scholar
• Terrazzino S, La Mattina P, Masini L, Caltavuturo T, Gambaro G, Canonico PL, Genazzani AA, Krengli M. (2012). Common variants of eNOS and XRCC1 genes may predict acute skin toxicity in breast cancer patients receiving radiotherapy after breast conserving surgery. Radiother Oncol 103:199–205.
   PubMed Web of Science ®Google Scholar
• Wu MT, Chen MC, Wu DC. (2004). Influences of lifestyle habits and p53 codon 72 and p21 codon 31 polymorphisms on gastric cancer risk in Taiwan. Cancer Lett 205:61–68.
   PubMed Web of Science ®Google Scholar
• Yang M, Guo Y, Zhang X, Miao X, Tan W, Sun T, Zhao D, Yu D, Liu J, Lin D. (2007). Interaction of P53 Arg72Pro and MDM2 T309G polymorphisms and their associations with risk of gastric cardia cancer. Carcinogenesis 28:1996–2001.
   PubMed Web of Science ®Google Scholar
• Yi SY, Lee WJ. (2006). A p53 genetic polymorphism of gastric cancer: Difference between early gastric cancer and advanced gastric cancer. World J Gastroenterol 12:6536–6539.
   PubMed Web of Science ®Google Scholar
• Zhang ZW, Newcomb P, Hollowood A, Feakins R, Moorghen M, Storey A, Farthing MJ, Alderson D, Holly J. (2003). Age-associated increase of codon 72 Arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma. Clin Cancer Res 9:2151–2156.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Li N, Zhuang W, Liu GJ, Wu TX, Yao X, Du L, Wei ML, Wu XT. (2007). P53 codon 72 polymorphism and gastric cancer: A meta-analysis of the literature. Int J Cancer 121:1481–1486.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Li N, Zhuang W, Wu X. (2010). p53 Codon 72 polymorphism and gastric cancer risk in a Chinese Han population. Genet Test Mol Biomarkers 14:829–833.
   PubMed Web of Science ®Google Scholar